Home > Healthcare > Medical Devices > Infection Control > Endoscope Reprocessing Market

Endoscope Reprocessing Market Trends

  • Report ID: GMI10131
  • Published Date: Jul 2024
  • Report Format: PDF

Endoscope Reprocessing Market Trends

The landscape of endoscope reprocessing is being reshaped by rapid advancements in medical technology, indicating a new era of precision cleaning and personalized reprocessing strategies.
 

  • Advancements in high-level disinfection (HLD) solutions have improved the effectiveness of endoscope reprocessing. Innovations such as peracetic acid, hydrogen peroxide-based sterilizers, and ozone-based systems provide superior microbial kill rates and shorter cycle times.
     
  • The integration of smart technologies, such as IoT and AI, in AERs to monitor and optimize the reprocessing cycle is expected to boost the market growth over the forecast period. These systems can provide real-time data, predictive maintenance alerts, and ensure compliance with reprocessing protocols.
     
  • Additionally, the introduction of enhanced automation capabilities to reduce human mistake and increase efficiency is expected to boost market growth. Advanced AERs now include capabilities such as automated leak testing, detergent dosing, and comprehensive disinfection cycles.
     
  • Moreover, the market is being shaped by a combination of technological innovation, regulatory pressures, and a heightened focus on patient safety and environmental sustainability. As healthcare providers strive to improve infection control and comply with stricter guidelines, the demand for advanced, efficient, and eco-friendly reprocessing solutions is expected to continue growing.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global endoscope reprocessing delivery industry was valued at USD 2.9 billion in 2023 and is anticipated to register 11.5% CAGR between 2024 and 2032, driven by the rising prevalence of gastrointestinal diseases, cancer, and other medical conditions.

The devices segment in the market was valued at USD 1.9 billion in 2023, owing to the growing use of endoscopic procedures in diagnostic and therapeutic applications.

North America endoscope reprocessing market is poised to reach USD 3.2 billion by 2032, attributed to the increasing incidence of gastrointestinal diseases, cancers, and other chronic conditions.

ARC Group of Companies Inc., ASP, Belimed, CONMED Corporation, Creo Medical, Ecolab, Getinge AB, Karl Storz, Metrex Research, LLC., and Olympus Corporation, among others.

Endoscope Reprocessing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 243
  • Countries covered: 36
  • Pages: 100
 Download Free Sample